Medicus Pharma Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Medicus Pharma Ltd.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than 96% of Healthcare companies in United States.
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 86% of its market value (net cash). Higher than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 0/3Sales and profit both fell in each of the last 3 years.
Less steady than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-4.3×Operating cash was negative last year, while some debt falls due within a year.
Higher than 60% of Healthcare companies in United States.
Cash Cushion Ratio
+86%Cash, after subtracting all debt, equals 86% of its market value (net cash).
Higher than 86% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Medicus Pharma Ltd. made a loss over the last year. Medicus Pharma Ltd. owes $1.06 for every $1 it owns. Medicus Pharma Ltd. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossMedicus Pharma Ltd. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-2.13Medicus Pharma Ltd.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$4 MThe total market value of all of Medicus Pharma Ltd.'s shares at today's price (share price × number of shares), smaller than 95% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
NegativeMedicus Pharma Ltd.'s net worth is negative ($2 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Return on equity (ROE)
-7446.1%Medicus Pharma Ltd. lost 7446.1% of its shareholders' money over the last year, lower than almost all Healthcare companies in United States.
Owes vs Owns
1.06×Medicus Pharma Ltd. owes $1.06 for every $1 it owns, so it owes more than it owns, higher than 89% of Healthcare companies in United States.
Dividend yield
NoneMedicus Pharma Ltd. does not currently pay a dividend.
Profit growth
LossMedicus Pharma Ltd. made a loss in each of the last two years.
Cash vs debt
Net cashMedicus Pharma Ltd. held $3 M more cash than debt (net cash) at Dec 2025.
Questions
What is Medicus Pharma Ltd.'s return on equity?
Medicus Pharma Ltd. lost 7446.1% of its shareholders' money over the last year, lower than almost all Healthcare companies in United States.
How much does Medicus Pharma Ltd. owe compared with what it owns?
Medicus Pharma Ltd. owes $1.06 for every $1 it owns, so it owes more than it owns, higher than 89% of Healthcare companies in United States.
Does Medicus Pharma Ltd. pay a dividend?
No. Medicus Pharma Ltd. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.